News - Anti-Arthritics/Rheumatics


Popular Filters

50 to 74 of 297 results

Enbrel and Humira remain the mainstay for first-line biologic rheumatoid arthritis treatment in USA


The vast majority of patients in the USA treated with Amgen's (Nasdaq: AMGN) Enbrel (etanercept) and…

AbbVieAmgenAnti-Arthritics/RheumaticsEnbrelHumiraMarkets & MarketingNorth AmericaPfizerPharmaceuticalXeljanz

EGA welcomes first biosimilar MAb approvals in Europe


Following the European Medicines Agency's CHMP recommendation, the European Commission (EC) has just…


First biosimilar monoclonal antibody approved in Europe


US injectables and infusion technologies firm Hospira (NYSE: HSP) says the European Commission has approved…

Anti-Arthritics/RheumaticsBiotechnologyCellTrionEuropeGenericsHospiraInflectraMerck & CoRemicadeResearch

SOBI restructures Kineret and Kepivance deals


Swedish Orphan Biovitrum (STO: SOBI) said this morning that it has acquired the full rights to develop…

AmgenAnti-Arthritics/RheumaticsBiotechnologyKepivanceKineretLicensingOncologyPharmaceuticalRare diseasesSwedish Orphan Biovitrum

Karo Bio gets first milestone in Pfizer collaboration


Under its collaboration with US pharma behemoth Pfizer (NYSE: PFE), Sweden's Karo Bio (STO: KARO) says…

Anti-Arthritics/RheumaticsDermatologicalsFinancialKaro BioLicensingNeurologicalPfizerPharmaceuticalResearch

Baxter and Coherus in up to $246 million deal for biosimilar etanercept


US companies Baxter International (NYSE:BAX) and Coherus Biosciences have entered into an exclusive collaboration…

AmgenAnti-Arthritics/RheumaticsBaxter InternationalBiotechnologyCoherus BioSciencesEnbreletanerceptGenericsLicensingResearch

EU approval for Ilaris in active systemic juvenile idiopathic arthritis


Following a positive recommendation from the European Medicines Agency's Committee for Medicinal Products…


German pharma watch dog finds benefits for biologicals in RA


The German Institute for Quality and Efficiency in Health Care (IQWiG) examined nine biotechnologically…

Anti-Arthritics/RheumaticsBiotechnologyCimziaEnbrelEuropeHumiraKineretMabTheraOrenciaPharmaceuticalPricingRegulationRemicadeRoActemraSimponi Injection

Phase III data support biosimilarity of BOW-015 to Remicade


Privately-held US biotech firm EPIRUS Biopharmaceuticals, which is focused on the development and production…

Anti-Arthritics/RheumaticsBiotechnologyEPIRUS BiopharmaceuticalsGenericsinfliximabRegulationRemicadeResearch

Horizon Pharma in Duexis patent settlement


Horizon Pharma (Nasdaq: HZNP) says it has entered into settlement and license agreements with Par Pharmaceutical…

Anti-Arthritics/RheumaticsDuexisGenericsHorizon PharmaNorth AmericaPar PharmaceuticalPatentsPharmaceutical

US FDA accepts Pennsaid 2% NDA for review


The US Food and Drug Administration has accepted for filing US drugmaker Mallinckrodt's (NYSE: MNK) New…

Anti-Arthritics/RheumaticsGenericsMallinckrodtNorth AmericaNuvo ResearchPennsaidPharmaceuticalRegulation

Nuvo Research files law suit against Mallinckrodt


Canadian specialty pharma company Nuvo Research (TSX: NRI) says it has commenced legal action against…

Anti-Arthritics/RheumaticsLegalLicensingMallinckrodtNorth AmericaNuvo ResearchPennsaidPharmaceutical

Ampio's osteoarthritis treatment shows key reduction in pain


USA-based biopharma firm Ampio Pharmaceuticals (Nasdaq: AMPE) has announced positive results from its…

Ampio PharmaceuticalsAmpionAnti-Arthritics/RheumaticsNorth AmericaPharmaceuticalResearch

EU5 rheumatologits rate Rituxan and Benlysta for Lupus


Rheumatologists in the top European nations ( EU5) countries (France, Germany, Italy, Spain, UK) give…

Anti-Arthritics/RheumaticsBenlystaBiogen IdecBristol-Myers SquibbEuropeGlaxoSmithKlineMarkets & MarketingOrenciaPharmaceuticalRituxanRoche

Mitsubishi Tanabe succeeds in arbitration


Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) says it has been awarded $117 million in an…

Anti-Arthritics/RheumaticsAsia-PacificJanssen BiotechJohnson & JohnsonLicensingMitsubishi TanabePharmaceuticalPricingRemicade

Mixed Ph II results with Isis-CRPRx in RA patients


US biotech firm Isis Pharmaceuticals (Nasdaq: ISIS) says that patients treated with ISIS-CRPRx achieved…

Anti-Arthritics/RheumaticsBiotechnologyIsis PharmaceuticalsIsis-CRPrxResearch

Two CHMP positives for Novartis


There was a flow of positive news from the European Medicines Agency on Friday (July 26) for Swiss drug…

Anti-Arthritics/RheumaticsEuropeIlarisNovartisPharmaceuticalRegulationRespiratory and PulmonaryUltibro BreezhalerVectura

Disappointment for Pfizer on negative CHMP view for Xeljanz


There was disappointment for US pharma behemoth Pfizer (NNYSE: PFE), when the European Medicines Agency's…


Transition in new licensing deal with Eli Lilly


Canada's Transition Therapeutics (TSX: TTH) has entered an exclusive licensing of worldwide rights to…

Anti-Arthritics/RheumaticsEli LillyLicensingPharmaceuticalTransition TherapeuticsTT-601

Galapagos and Servier celebrate late stage discovery milestone


Belgium-based Galapagos (Euronext: GLPG) has announced a late stage discovery milestone for small molecules…


Nuvo's partner Mallinckrodt to resubmit osteoarthritis treatment to US FDA


Canada's Nuvo Research (TSX: NRI) says that its licensing partner Mallinckrodt (NYSE: MNK) has successfully…

Anti-Arthritics/RheumaticsCovidienMallinckrodtNorth AmericaNuvo ResearchPennsaidPharmaceuticalRegulation

Simponi ARIA cleared by US FDA


US health care giant Johnson & Johnson's (NYSE: JNJ) Janssen Biotech subsidiary has received US Food…

Anti-Arthritics/RheumaticsBiotechnologyJanssen BiotechJohnson & JohnsonNorth AmericaPharmaceuticalRegulationSimponi ARIA

Pfizer gets Swiss nod for Xeljanz for rheumatoid arthritis


US drug giant Pfizer (NYSE: PFE) said its rheumatoid arthritis (RA) therapy Xeljanz (tofacitinib) has…

Anti-Arthritics/RheumaticsEuropePfizerPharmaceuticalRegulationTakeda NycomedXeljanz

Russia's R-Pharm to develop UCB's olokizumab for rheumatoid arthritis


Belgium's leading pharma company UCB (Euronext Brussels: UCB) said today (July 4) that it has granted…


50 to 74 of 297 results

Back to top